<DOC>
	<DOCNO>NCT00002955</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient advanced cancer pancreas .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Advanced Cancer Pancreas</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate tumor response trimetrexate , fluorouracil leucovorin regimen patient advance pancreatic carcinoma . II . Evaluate toxicity associate regimen patient metastatic carcinoma pancreas . OUTLINE : The treatment plan consist IV infusion trimetrexate , follow 24 hour later IV infusion leucovorin fluorouracil . After another 24 hour oral leucovorin give every 6 hour 7 dos . A treatment cycle consist regimen repeat weekly 6 week follow 2 week rest . Treatment cycle repeat disease progression unacceptable toxicity . PROJECTED ACCRUAL : If 3 complete partial response observe first 22 patient , additional 11 patient may accrue maximum 33 .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Trimetrexate</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven advanced pancreatic cancer metastatic disease Bidimensionally measurable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Hematopoietic : Platelet count least 100,000/mm3 Absolute granulocyte count least 1,500/mm3 Hemoglobin least 9 g/dL Hepatic : Bilirubin great 2.0 mg/dL SGOT , SGPT alkaline phosphatase less 3 time upper limit normal Serum albumin least 3.0 g/dL Renal : Serum creatinine great 1.5 mg/dL Other : Not eligible high priority protocol No prior malignancy within 5 year except adequately treat basal cell carcinoma skin carcinoma situ cervix Not pregnant nursing Fertile patient must use effective birth control No underlying medical condition precluding treatment PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : No concurrent radiotherapy No prior radiotherapy site ( ) measurable disease Fully recover therapy Surgery : Fully recover prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>